Gastrointestinal Neoplasms research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
This study is testing a new drug, IDRX-42, for people with advanced gastrointestinal stromal tumors (GIST). It's the first time this drug is being used in humans. We want to see if it's safe, how the body handles it, and if it helps shrink tumors.
United States · Belgium · China - recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
The OSPREY Registry is looking at how a device called OncoSil™ works in people with locally advanced pancreatic cancer in normal hospital care. It watches how well the device performs and if there are any side effects when used with standard chemotherapy.
Spain · United Kingdom - recruiting
Early Diagnosis of Upper Digestive Tract Disease
This study is looking for an easier way to find cancers in the upper part of your digestive system, like the mouth, throat, and stomach. Researchers are testing if a simple breath, spit, and urine test can help diagnose these cancers early.
United Kingdom